INSMED ANNOUNCES POSITIVE 12-MONTH DATA FROM THE ONGOING OPEN-LABEL EXTENSION STUDY OF TREPROSTINIL PALMITIL INHALATION POWDER (TPIP) IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

Reuters · 2d ago

Please log in to view news